Evaluation of Protein in the Urine in Patients Receiving Bevacizumab
An Evaluation of Proteinuria in Patients Receiving Shortened Infusions of Bevacizumab
Sponsor: North Texas Veterans Healthcare System
A observational or N/A phase clinical study on Colon Cancer and Rectal Cancer, this trial is completed. The trial is conducted by North Texas Veterans Healthcare System and has accumulated 6 data snapshots since 2007. Oncology trials at this stage typically focus on safety, tolerability, and early efficacy signals.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Completed
-
Jul 2024 — Sep 2024 [monthly]
Completed
-
Jan 2021 — Jul 2024 [monthly]
Completed
-
Jun 2018 — Jan 2021 [monthly]
Completed
-
Apr 2018 — Jun 2018 [monthly]
Completed
Phase: NA → None
▶ Show 1 earlier version
-
Jan 2017 — Apr 2018 [monthly]
Completed NA
First recorded
Nov 2007
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- North Texas Veterans Healthcare System
- University of Texas Southwestern Medical Center
For direct contact, visit the study record on ClinicalTrials.gov .